Login to Your Account



Ex-U.S. Denosumab: Up to $120M

GSK Deal, Strong Quarter Get Amgen High Wall Street Marks

By Randy Osborne


Tuesday, July 28, 2009
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription